Axplora- The partner of choice for complex APIs.
01 1Axplora
02 1Dr. Reddy's Laboratories
03 1Biophore India Pharmaceuticals Pvt Ltd
04 1LGM Pharma
05 1Aarti Pharmalabs
06 1Chongqing Sintaho Pharmaceutical
07 1Jinan Tantu Chemicals
08 1Shandong Boyuan Pharmaceutical
09 1Tofigh Daru
10 1ALP Pharm
11 1Alembic Pharmaceuticals Limited
12 1Beijing Mesochem Technology
13 1Cambrex Corporation
14 1Cdymax
15 1Cipla
16 1Deva Holding AS
17 1Glenmark Life Sciences
18 1Haoyuan Chemexpress Co.Ltd
19 1Hetero Drugs
20 2MSN Laboratories
21 1Mac-Chem Products (India) Pvt.Ltd
22 1Morepen Laboratories
23 1Olon S.p.A
24 1ScinoPharm Taiwan, Ltd
25 1Shandong Anhong Pharmaceutical
26 1Shanghai Hope Chem
27 1Sun-shine Chem
28 1Wisdom Pharmaceutical
01 10China
02 1Germany
03 12India
04 1Iran
05 1Italy
06 1Taiwan
07 1Turkey
08 2U.S.A
01 13Active
02 16Blank
01 29Blank
01 29Blank
01 1WC-0082
02 1WC-0349
03 1WC-0349A12
04 26Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-04-19
Pay. Date : 2022-03-31
DMF Number : 35742
Submission : 2021-03-30
Status : Active
Type : II
NDC Package Code : 71796-034
Start Marketing Date : 2021-11-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40467
Submission : 2024-09-28
Status : Active
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Jinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.
Tofigh Daru develops & synthesizes a diverse range of APIs in Anticancer, Narcotics, Cardiovascular to Immunomodulatory Segments.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38957
Submission : 2023-09-28
Status : Active
Type : II
We have 28 companies offering Olaparib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?